International Journal of Cardiology
Volume 135, Issue 2 , Pages 202-206 , 26 June 2009

Association of plasma level of malondialdehyde-modified low-density lipoprotein with coronary plaque morphology in patients with coronary spastic angina: Implication of acute coronary events

  • Shigemasa Tani

      Affiliations

    • Department of Cardiology, Nihon University Surugadai Hospital, Tokyo Japan
    • Division of Cardiovascular Medicine, Department of Medicine, Nihon University School of Medicine, Tokyo Japan
    • Corresponding Author InformationCorresponding author. Department of Cardiology, Nihon University Surugadai Hospital, 1-8-13 Kanda-Surugadai Chiyoda-ku, Tokyo 101-8309, Japan. Tel.: +81 3 3293 1711; fax: +81 3 3295 1859.
    • ,
  • Ken Nagao

      Affiliations

    • Department of Cardiology, Nihon University Surugadai Hospital, Tokyo Japan
    • Division of Cardiovascular Medicine, Department of Medicine, Nihon University School of Medicine, Tokyo Japan
    • ,
  • Takeo Anazawa

      Affiliations

    • Department of Cardiology, Nihon University Surugadai Hospital, Tokyo Japan
    • Division of Cardiovascular Medicine, Department of Medicine, Nihon University School of Medicine, Tokyo Japan
    • ,
  • Hirofumi Kawamata

      Affiliations

    • Department of Cardiology, Nihon University Surugadai Hospital, Tokyo Japan
    • Division of Cardiovascular Medicine, Department of Medicine, Nihon University School of Medicine, Tokyo Japan
    • ,
  • Shingo Furuya

      Affiliations

    • Department of Cardiology, Nihon University Surugadai Hospital, Tokyo Japan
    • Division of Cardiovascular Medicine, Department of Medicine, Nihon University School of Medicine, Tokyo Japan
    • ,
  • Takeshi Fuji

      Affiliations

    • Department of Cardiology, Nihon University Surugadai Hospital, Tokyo Japan
    • Division of Cardiovascular Medicine, Department of Medicine, Nihon University School of Medicine, Tokyo Japan
    • ,
  • Hiroshi Takahashi

      Affiliations

    • Department of Cardiology, Nihon University Surugadai Hospital, Tokyo Japan
    • Division of Cardiovascular Medicine, Department of Medicine, Nihon University School of Medicine, Tokyo Japan
    • ,
  • Kiyoshi Iida

      Affiliations

    • Department of Cardiology, Nihon University Surugadai Hospital, Tokyo Japan
    • Division of Cardiovascular Medicine, Department of Medicine, Nihon University School of Medicine, Tokyo Japan
    • ,
  • Michiaki Matsumoto

      Affiliations

    • Department of Cardiology, Nihon University Surugadai Hospital, Tokyo Japan
    • Division of Cardiovascular Medicine, Department of Medicine, Nihon University School of Medicine, Tokyo Japan
    • ,
  • Takamichi Kumabe

      Affiliations

    • Department of Cardiology, Nihon University Surugadai Hospital, Tokyo Japan
    • Division of Cardiovascular Medicine, Department of Medicine, Nihon University School of Medicine, Tokyo Japan
    • ,
  • Yuichi Sato

      Affiliations

    • Department of Cardiology, Nihon University Surugadai Hospital, Tokyo Japan
    • Division of Cardiovascular Medicine, Department of Medicine, Nihon University School of Medicine, Tokyo Japan
    • ,
  • Atsushi Hirayama

      Affiliations

    • Division of Cardiovascular Medicine, Department of Medicine, Nihon University School of Medicine, Tokyo Japan

Received 16 September 2007 ,Revised 8 February 2008 ,Accepted 29 March 2008.

References 

  1. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation. 1995;92:657–671
  2. Tiefenbrunn AJ, Sobel BE, Gowda S, McKnight RC, Ludbrook PA. Nifedipine blockade of ergonovine-induced coronary arterial spasm: angiographic documentation. Am J Cardiol. 1981;48:184–187
  3. Myerburg RJ, Kessler KM, Mallon SM, Cox MM, deMarchena E, Interian A. Castellanos A. Life-threatening ventricular arrhythmias in patients with silent myocardial ischemia due to coronary-artery spasm. N Engl J Med. 1992;326:1451–1455
  4. Mori F, Uchida T, Byun T, et al. Cardiac events in vasospastic angina: site and morphology of coronary artery spasm is related to the long-term prognosis of vasospastic angina. J Cardiol. 1999;33:191–199
  5. Yla-Herttuala S, Palinski W, Butler SW, Picard S, Steinberg D, Witztum JL. Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. Arterioscler Thromb. 1994;14:32–40
  6. Holvoet P, Vanhaecke J, Janssens S, Van de Werf F, Collen D. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation. 1998;98:1487–1494
  7. Tani S, Watanabe I, Anazawa T, et al. Surugadai Atherosclerosis Regression Investigators. Effect of pravastatin on malondialdehyde-modified low-density lipoprotein levels and coronary plaque regression as determined by three-dimensional intravascular ultrasound. Am J Cardiol. 2005;96:1089–1094
  8. Yasue H, Takizawa A, Nagao M, et al. Long-term prognosis for patients with variant angina and influential factors. Circulation. 1988;78:1–9
  9. Tani S, Nagao K, Anazawa T, Kawamata H, Iida K, Matsumoto M, et al. Association of circulating leukocyte count with coronary atherosclerosis regression after pravastatin treatment. Atherosclerosis. 2008;198(2):360–365
  10. Koyama J, Yamagishi M, Tamai J, Kawano S, Daikoku S, Miyatake K. Comparison of vessel wall morphology between sites with focal and diffuse coronary vasospasm: study by intravascular ultrasound. Am Heart J. 1995;130:440–445
  11. Koizumi T, Yokoyama M, Namikawa S, et al. Location of focal vasospasm provoked by ergonovine maleate within coronary arteries in patients with vasospastic angina pectoris. Am J Cardiol. 2006;97:1322–1325
  12. Beltrame JF, Sasayama S, Maseri A. Racial heterogeneity in coronary artery vasomotor reactivity: differences between Japanese and Caucasian patients. J Am Coll Cardiol. 1999;33:1442–1452
  13. Holvoet P, Stassen JM, Van Cleemput J, Collen D, Vanhaecke J. Oxidize low density lipoproteins in patients with transplant-associated coronary artery disease. Arterioscler Thromb Vasc Biol. 1998;18:100–107
  14. Witztum JL, Steinberg D. Role of oxidized low-density lipoprotein in atherogenesis. J Clin Invest. 1991;88:160–162
  15. Kugiyama K, Sugiyama S, Soejima H, et al. Increase in plasma levels of oxidized low-density lipoproteins in patients with coronary spastic angina. Atherosclerosis. 2001;154:463–467
  16. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332:411–415
  17. Hayashida K, Kume N, Murase T, et al. Serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are elevated in acute coronary syndrome: a novel marker for early diagnosis. Circulation. 2005;112:812–818
  18. Etsuda H, Mizuno K, Arakawa K, Satomura K, Shibuya T, Isojima K. Angioscopy in variant angina: coronary artery spasm and intimal injury. Lancet. 1993;342:1322–1324
  19. Miyamoto S, Ogawa H, Soejima H, et al. Formation of platelet aggregates after attacks of coronary spastic angina pectoris. Am J Cardiol. 2000;85:494–497

PII: S0167-5273(08)00518-4

doi: 10.1016/j.ijcard.2008.03.071

International Journal of Cardiology
Volume 135, Issue 2 , Pages 202-206 , 26 June 2009

Article Tools

* Image Usage & Resolution